Savara announces new employment inducement grant under nasdaq listing rule 5635(c)(4)

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that on may 11, 2021, the compensation committee of the company's board of directors granted a newly hired employee the option to purchase 175,000 shares of the company's common stock and restricted stock units (rsus) covering 100,000 shares of the company's common stock. these equity awards were granted pursuant to rule 5635(c)(4) of the n
SVRA Ratings Summary
SVRA Quant Ranking